Victory Capital Management
LUCD icon

Victory Capital Management’s Lucid Diagnostics LUCD Stock Holding History

Victory Capital Management’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.6K Sell
10,113
-722
-7% -$919 ﹤0.01% 2392
2025
Q4 		$11.8K Buy
+10,835
New +$12.1K ﹤0.01% 2406

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Victory Capital Management's LUCD Position: Q1 2026 in Review

Victory Capital Management reduced its Lucid Diagnostics (LUCD) stake by 6.7% in Q1 2026, selling an estimated $919 and leaving 10,113 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2392.

Victory Capital Management first reported a position in LUCD in Q4 2025 and has held it in 2 quarters since. The position peaked at $11.8K in Q4 2025. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Victory Capital Management held 10,113 shares of Lucid Diagnostics worth $11.6K as of Q1 2026.
  • Victory Capital Management sold 722 Lucid Diagnostics shares in Q1 2026, an estimated $919.
  • Lucid Diagnostics made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #2392 holding.
  • Victory Capital Management first reported a position in Lucid Diagnostics in Q4 2025 and has held it in 2 quarters since.
  • Victory Capital Management's Lucid Diagnostics position peaked at $11.8K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.